Literature DB >> 32833215

Determining How Coronaviruses Overcome the Interferon and Innate Immune Response.

Christopher M Coleman1.   

Abstract

All viruses have to overcome the innate immune response in order to establish infection. Methods have been developed to assay if, and how, viruses overcome these responses, and many can be directly applied to coronaviruses. Here, in vitro methods to determine how coronaviruses overcome this response are described.

Entities:  

Keywords:  Antagonism of innate immunity; Coronaviruses; Innate immunity; Interferon; Virus protein function

Mesh：

Substances：

Year:  2020        PMID： 32833215     DOI： 10.1007/978-1-0716-0900-2_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  11 in total

1.  The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling.

Authors:  Krystal L Matthews; Christopher M Coleman; Yvonne van der Meer; Eric J Snijder; Matthew B Frieman
Journal:  J Gen Virol       Date:  2014-01-17       Impact factor: 3.891

2.  CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.

Authors:  Christopher M Coleman; Jeanne M Sisk; Gabor Halasz; Jixin Zhong; Sarah E Beck; Krystal L Matthews; Thiagarajan Venkataraman; Sanjay Rajagopalan; Christos A Kyratsous; Matthew B Frieman
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.

Authors:  Justin K Taylor; Christopher M Coleman; Sandra Postel; Jeanne M Sisk; John G Bernbaum; Thiagarajan Venkataraman; Eric J Sundberg; Matthew B Frieman
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

4.  Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.

Authors:  Trevor Scobey; Boyd L Yount; Amy C Sims; Eric F Donaldson; Sudhakar S Agnihothram; Vineet D Menachery; Rachel L Graham; Jesica Swanstrom; Peter F Bove; Jeeho D Kim; Sonia Grego; Scott H Randell; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

5.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 6.  RIG-I in RNA virus recognition.

Authors:  Alison M Kell; Michael Gale
Journal:  Virology       Date:  2015-03-05       Impact factor: 3.616

7.  Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate.

Authors:  Fernando Almazán; Marta L DeDiego; Isabel Sola; Sonia Zuñiga; Jose L Nieto-Torres; Silvia Marquez-Jurado; German Andrés; Luis Enjuanes
Journal:  mBio       Date:  2013-09-10       Impact factor: 7.867

Review 8.  RIG-I-like receptor-induced IRF3 mediated pathway of apoptosis (RIPA): a new antiviral pathway.

Authors:  Saurabh Chattopadhyay; Ganes C Sen
Journal:  Protein Cell       Date:  2016-11-04       Impact factor: 14.870

9.  BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface.

Authors:  Shiu-Mei Wang; Kuo-Jung Huang; Chin-Tien Wang
Journal:  Virology       Date:  2013-12-15       Impact factor: 3.616

10.  Growth and Quantification of MERS-CoV Infection.

Authors:  Christopher M Coleman; Matthew B Frieman
Journal:  Curr Protoc Microbiol       Date:  2015-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.